About CHF Solutions (NASDAQ:CHFS)
CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It offers Aquadex FlexFlow consoles and the related disposable products in Singapore and Hong Kong. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.
Industry, Sector and Symbol
Industry Electromedical equipment
Trailing P/E Ratio-0.07
Forward P/E Ratio-0.80
Sales & Book Value
Annual Sales$3.55 million
Price / Sales3.44
Price / CashN/A
Book Value$4.27 per share
Price / Book0.63
EPS (Most Recent Fiscal Year)($37.15)
Return on Equity-149.00%
Return on Assets-124.42%
CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions
What is CHF Solutions' stock symbol?
CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS."
When did CHF Solutions' stock split? How did CHF Solutions' stock split work?
CHF Solutions's stock reverse split before market open on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split.
How were CHF Solutions' earnings last quarter?
CHF Solutions Inc (NASDAQ:CHFS) issued its quarterly earnings results on Tuesday, May, 8th. The company reported ($1.08) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.61) by $0.47. The business had revenue of $1.04 million for the quarter. CHF Solutions had a negative net margin of 455.30% and a negative return on equity of 149.00%. View CHF Solutions' Earnings History.
When is CHF Solutions' next earnings date?
What price target have analysts set for CHFS?
1 equities research analysts have issued 1-year target prices for CHF Solutions' stock. Their predictions range from $65.00 to $65.00. On average, they anticipate CHF Solutions' share price to reach $65.00 in the next twelve months. View Analyst Ratings for CHF Solutions.
Who are some of CHF Solutions' key competitors?
Some companies that are related to CHF Solutions include Soleno Therapeutics (SLNO), Stereotaxis (STXS), Digirad (DRAD), Aradigm (ARDM), Dynatronics (DYNT), Nexeon Medsystems (NXNN), Non-Invasive Monitoring System (NIMU), ENDRA Life Sciences (NDRA), Fc Global Realty (FCRE), Reshape Lifesciences (RSLS), Vaso (VASO), Precision Optics (PEYE), Escalon Medical (ESMC), Trimedyne (TMED) and 21st North (ULGX).
Who are CHF Solutions' key executives?
CHF Solutions' management team includes the folowing people:
- Mr. John L. Erb, Chairman, CEO & Pres (Age 69)
- Ms. Claudia Napal Drayton, CFO & Sec. (Age 50)
- Mr. Vitaliy Epshteyn, VP of Operations & Engineering (Age 40)
- Ms. Sandra Eayrs, VP of HR
- Ms. Megan Brandt, Sr. VP of Medical Affairs & Healthcare Policy
Has CHF Solutions been receiving favorable news coverage?
Press coverage about CHFS stock has trended somewhat negative this week, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CHF Solutions earned a coverage optimism score of -0.13 on Accern's scale. They also assigned news coverage about the company an impact score of 45.69 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
Who are CHF Solutions' major shareholders?
CHF Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Sabby Management LLC (4.01%). Company insiders that own CHF Solutions stock include John L Erb and Ki Yong Choi. View Institutional Ownership Trends for CHF Solutions.
Which major investors are buying CHF Solutions stock?
CHFS stock was bought by a variety of institutional investors in the last quarter, including Sabby Management LLC. Company insiders that have bought CHF Solutions stock in the last two years include John L Erb and Ki Yong Choi. View Insider Buying and Selling for CHF Solutions.
How do I buy shares of CHF Solutions?
Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CHF Solutions' stock price today?
One share of CHFS stock can currently be purchased for approximately $2.71.
How big of a company is CHF Solutions?
CHF Solutions has a market capitalization of $12.20 million and generates $3.55 million in revenue each year. The company earns $-13,380,000.00 in net income (profit) each year or ($37.15) on an earnings per share basis. CHF Solutions employs 46 workers across the globe.
How can I contact CHF Solutions?
CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected]
MarketBeat Community Rating for CHF Solutions (CHFS)MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote "Outperform" if you believe CHFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days.